Omeros Corporation — Cash Flow (NASDAQ:OMER) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 100.09 M109.72 M86.5 M74.7 M148.8 M 105.28 M Cash from investing activities 67.03 M193.71 M127.56 M27.45 M82.22 M 87.93 M Cash from financing activities 174.53 M6.32 M124.25 M106.08 M62.88 M 18.18 M Free cash flow 99.8 M109.44 M86.39 M74.27 M148.63 M 105.19 M

News

Omeros stock rises as first commercial YARTEMLEA shipments begin

Omeros begins commercial distribution of TA-TMA treatment Yartemlea

Omeros VP Borges sells $750k in shares

Omeros Corporation (OMER) Discusses FDA Approval and Commercialization Plans for YARTEMLEA in TA-TMA Treatment Transcript

Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA

Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (NASDAQ:OMER)

Biohaven, Omeros And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Andersen Group (NYSE:ANDG), Biohaven (NYSE:BHVN)

Why Davis Commodities Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AlphaTON Capital (NASDAQ:ATON), Biohaven (NYSE:BHVN)

NKE, OMER, MU, INTC, DVAX: 5 Trending Stocks Today - Nike (NYSE:NKE)

Omeros: Stock Pops On Yartemlea Approval, Longer-Term Upside Likely (NASDAQ:OMER)

Micron Tech and Nike among market cap stock movers on Wednesday

Omeros stock soars after FDA approves first treatment for TA-TMA